![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, November 02, 2021 4:40:40 PM
Recent ARTL News
- Artelo Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/13/2024 12:00:00 PM
- Artelo Biosciences Receives FDA Clearance of its IND Application for ART26.12, a Selective Fatty Acid Binding Protein 5 Inhibitor • GlobeNewswire Inc. • 07/15/2024 12:30:00 PM
- Artelo Biosciences Presents Comparative Data from Key Preclinical Studies on ART12.11 at the 34th Annual International Cannabinoid Research Society Symposium • GlobeNewswire Inc. • 07/03/2024 01:00:00 PM
- Artelo Biosciences Announces Data Supporting Broad Potential Utility of its FABP Inhibitor Platform • GlobeNewswire Inc. • 07/02/2024 01:00:00 PM
- Artelo Biosciences Presents Preclinical Data on ART26.12 in Breast Cancer-Induced Bone Pain at the 34th Annual International Cannabinoid Research Society Symposium • GlobeNewswire Inc. • 07/01/2024 01:00:00 PM
- Artelo Biosciences Presents Important New Data on ART26.12 at the 57th Annual Scientific Meeting of the British Pain Society • GlobeNewswire Inc. • 06/04/2024 12:30:00 PM
- Artelo Biosciences Presents Highly Encouraging Data Towards Developing a Solid Dosage Form of ART12.11 at CT-CANN24 • GlobeNewswire Inc. • 05/29/2024 12:30:00 PM
- Artelo Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/13/2024 12:00:00 PM
- Artelo Biosciences to Present at the Pharma Partnering Summit 2024 on May 14th • GlobeNewswire Inc. • 05/10/2024 01:00:00 PM
- Artelo Biosciences Announces Publication of Peer-Reviewed Article Highlighting FABP7 as a Promising Novel Target in Cancer Therapy • GlobeNewswire Inc. • 04/23/2024 12:30:00 PM
- Artelo Biosciences CEO to Appear on Benzinga All Access on April 23rd at Approximately 10:50 AM Eastern Time • GlobeNewswire Inc. • 04/22/2024 12:30:00 PM
- Artelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business Update • GlobeNewswire Inc. • 03/25/2024 12:00:00 PM
- Artelo Biosciences Selected as a Finalist in Johnson & Johnson’s Innovation Challenge • GlobeNewswire Inc. • 03/12/2024 01:15:00 PM
- Artelo Biosciences Announces Publication of New Peer-Reviewed Pre-Clinical Research Demonstrating ART26.12’s Effectiveness in Treating and Preventing Oxaliplatin-Induced Peripheral Neuropathy • GlobeNewswire Inc. • 01/23/2024 01:30:00 PM
- Artelo Biosciences Announces Selection of Worldwide Clinical Trials as Clinical Research Organization to Support First-in-Human Study of ART26.12 • GlobeNewswire Inc. • 01/08/2024 01:30:00 PM
- Artelo Biosciences Presents New Preclinical Data on ART12.11 at the 4th Annual Med-Cannabis 2023 Conference in Germany • GlobeNewswire Inc. • 12/05/2023 01:30:00 PM
- Artelo Biosciences to Present Important New Preclinical Data on ART12.11 at the 4th Annual Med-Cannabis 2023 Conference in Germany • GlobeNewswire Inc. • 11/30/2023 02:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 01:02:44 PM
- Artelo Biosciences Reports Third Quarter 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 11/13/2023 01:00:00 PM
- Artelo Biosciences Announces Publication of New Peer-Reviewed Research Demonstrating Protective Properties of ART27.13 Against Muscle Degeneration Caused by Certain Cancers • GlobeNewswire Inc. • 11/09/2023 02:00:00 PM
- Artelo Biosciences to Present Preclinical Data Showcasing Research on ART26.12 and ART12.11 in Anxiety and Depression at Neuroscience 2023 • GlobeNewswire Inc. • 11/02/2023 12:30:00 PM
- Principal Investigator of Artelo’s CAReS Trial to Participate in Medical Expert Webinar Hosted by H.C. Wainwright to Discuss Current Development Strategies for Cancer-Related Anorexia and Cachexia • GlobeNewswire Inc. • 10/04/2023 12:30:00 PM
- Artelo Biosciences to Present at the 13th Congress of the European Pain Federation on September 20th • GlobeNewswire Inc. • 09/13/2023 12:30:00 PM
- Artelo Biosciences Completes Positive Pre-IND Meeting with FDA for ART26.12 • GlobeNewswire Inc. • 09/07/2023 12:00:00 PM
- Artelo Biosciences to Present at the 6th Cannabinoid-Derived Drug Development Summit on September 12th • GlobeNewswire Inc. • 09/06/2023 01:00:00 PM
HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM
PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM
VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM
Swifty Global Reports Strong Q2 Performance and Prepares for Major Exchange Uplisting • DRCR • Aug 15, 2024 9:04 AM
Mayback's Global Entertainment Signs Global Distribution Agreement with Children's Media Studio • AHRO • Aug 15, 2024 8:45 AM
POET Technologies Reports Second Quarter 2024 Financial Results • POET • Aug 15, 2024 8:04 AM